IL157600A0 - Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors - Google Patents

Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors

Info

Publication number
IL157600A0
IL157600A0 IL15760002A IL15760002A IL157600A0 IL 157600 A0 IL157600 A0 IL 157600A0 IL 15760002 A IL15760002 A IL 15760002A IL 15760002 A IL15760002 A IL 15760002A IL 157600 A0 IL157600 A0 IL 157600A0
Authority
IL
Israel
Prior art keywords
hematopoietic
differentiation
growth
stem cells
promoters
Prior art date
Application number
IL15760002A
Other languages
English (en)
Original Assignee
Daiichi Suntory Pharma Co Ltd
Daiichi Suntory Biomedical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd, Daiichi Suntory Biomedical Res filed Critical Daiichi Suntory Pharma Co Ltd
Publication of IL157600A0 publication Critical patent/IL157600A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15760002A 2001-12-28 2002-12-27 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors IL157600A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001400330 2001-12-28
PCT/JP2002/013862 WO2003057241A1 (fr) 2001-12-28 2002-12-27 Agents favorisant la proliferation et/ou la differenciation de cellules souches hematopoietiques et/ou de precurseurs hematopoietiques

Publications (1)

Publication Number Publication Date
IL157600A0 true IL157600A0 (en) 2004-03-28

Family

ID=19189604

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15760002A IL157600A0 (en) 2001-12-28 2002-12-27 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors

Country Status (13)

Country Link
US (1) US7282201B2 (es)
EP (1) EP1459758B1 (es)
JP (1) JP4362066B2 (es)
KR (1) KR100948346B1 (es)
CN (1) CN1329078C (es)
AT (1) ATE423567T1 (es)
AU (1) AU2002359951B8 (es)
BR (1) BR0207725A (es)
CA (1) CA2439471A1 (es)
DE (1) DE60231328D1 (es)
ES (1) ES2321819T3 (es)
IL (1) IL157600A0 (es)
WO (1) WO2003057241A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045064A2 (en) * 2004-10-20 2006-04-27 Whitehead Institute For Biomedical Research Cultured hematopoietic stem cells and method for expansion and analysis thereof
US7807464B2 (en) * 2005-05-24 2010-10-05 Whitehead Institute For Biomedical Research Methods for expansion and analysis of cultured hematopoietic stem cells
US20090123560A1 (en) * 2005-09-16 2009-05-14 Kenji Yoshida Hematopoietic Stem Cell Proliferation Inducing Agent
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
KR100980849B1 (ko) * 2007-04-25 2010-09-10 가톨릭대학교 산학협력단 인터루킨(ｉｌ)-10을 포함하는 조혈모세포의 자가 재생산을촉진하는 조성물
JP2010525836A (ja) * 2007-05-04 2010-07-29 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ ヒト造血幹細胞のｅｘｖｉｖｏ増殖
WO2009069133A2 (en) * 2007-11-28 2009-06-04 Hadasit Medical Research Services And Development Ltd. Methods for the treatment of radiation or chemotherapy-induced tissue damage
PE20100362A1 (es) 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
JP5519994B2 (ja) * 2009-10-19 2014-06-11 日揮株式会社 細胞培養装置及び細胞培養方法
US20130331326A1 (en) * 2011-02-21 2013-12-12 Duke University Method of inducing hematopoietic reconstruction
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
WO2024137866A2 (en) * 2022-12-23 2024-06-27 Emory University Methods of treating stroke or other blood clotting disorders using cofilin or derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
JPH0550603A (ja) 1991-08-22 1993-03-02 Fujitsu Ltd 印字装置
JP4052680B2 (ja) 1993-03-18 2008-02-27 アスビオファーマ株式会社 新規ヒト白血病細胞株
US6011051A (en) 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US5856330A (en) 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
GB0224014D0 (en) * 2002-10-15 2002-11-27 Oxford Glycosciences Uk Ltd A protein involved in therapy

Also Published As

Publication number Publication date
US7282201B2 (en) 2007-10-16
AU2002359951B2 (en) 2008-06-19
KR100948346B1 (ko) 2010-03-22
AU2002359951A1 (en) 2003-07-24
EP1459758A4 (en) 2006-02-22
JP4362066B2 (ja) 2009-11-11
EP1459758A1 (en) 2004-09-22
AU2002359951B8 (en) 2008-11-06
CA2439471A1 (en) 2003-07-17
CN1499980A (zh) 2004-05-26
CN1329078C (zh) 2007-08-01
ATE423567T1 (de) 2009-03-15
US20040157326A1 (en) 2004-08-12
WO2003057241A1 (fr) 2003-07-17
KR20040075700A (ko) 2004-08-30
EP1459758B1 (en) 2009-02-25
DE60231328D1 (de) 2009-04-09
ES2321819T3 (es) 2009-06-12
BR0207725A (pt) 2004-03-23
JPWO2003057241A1 (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
IL157600A0 (en) Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors
WO2001085664A8 (en) Compounds and methods for regulating bacterial growth and pathogenesis
MX336807B (es) Composiciones y metodos para producir una composicion.
WO2006026570A3 (en) Use of stem cells to generate inner ear cells
ZA200307161B (en) Medical aerosol formulations
WO2002064096A3 (en) Methods of using pyrimidine-based antiviral agents
MXPA03007942A (es) Preparaciones de insulina exentas de zinc y con bajo contenido de zinc, que tienen una estabilidad mejorada.
MXPA04000359A (es) Material bioactivo de implante espinal, y metodo para fabricar el mismo.
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2005030169A8 (en) Methods for preparing oil bodies comprising active ingredients
CA2318398A1 (en) Novel peptides having biological activity
HRP20080612T3 (en) Combination of tenofovir, ritonavir and tmc114
SG167670A1 (en) Aminocyclohexyl ether compounds and uses thereof
TW200507767A (en) Compositions containing coenzyme Q10
AU2002322857A1 (en) Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
MXPA04000874A (es) Composicion funguicida y uso de la composicion para controlar las enfermedades de las plantas.
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
BRPI0520129A2 (pt) uso de 5'-metiltioadenosina (mta) na prevenÇço e/ou no tratamento de doenÇas auto-imunes e/ou rejeiÇço de transplante
WO2003087353A3 (en) Purified polypeptides involved in membrane biogenesis
MY140724A (en) Novel arylethene-sulfonamides
WO2004044127A3 (en) Stem cell populations
WO2005037219A3 (en) Disinfecting teat care compositions
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
AU2002364506A1 (en) Compositions for the derivation of germ cells from stem cells and methods of use thereof

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees